Want to see GB:SBTX full AI Analyst Report?

SkinBioTherapeutics (SBTX) Revenue

24 Followers

SkinBioTherapeutics Revenue

SkinBioTherapeutics had a revenue of 2.17M in the quarter ending Dec 31, 2024, with -29.25%. This bring the company's revenue in the last twelve months to 5.23M, Decreased 12.70%. In the fiscal year ending Jun 30, 2024, SkinBioTherapeutics had annual revenue of 4.64M with 283.63% growth.

Revenue (ttm)

5.23M

Revenue Growth

95.16%

P/S Ratio

3.07

Revenue/Employee

£113,126

Employees

Market Cap

£14.25M

Revenue Chart

Revenue History

Fiscal End Date	Revenue	Change	Growth
Jun 30, 2024	4.64M	3.43M	+283.63%
Jun 30, 2023	1.21M	1.08M	+815.51%
Jun 30, 2022	132.06K	57.30K	+76.64%
Jun 30, 2021	74.76K	―	+∞%
Jun 30, 2020	―	―	―
Jun 30, 2019	―	―	―
Jun 30, 2018	―	―	―
Jun 30, 2018	―	―	―